Preview

Russian Journal of Cardiology

Advanced search

Lipoprotein profile in girls with asymptomatic hyperuricemia

Abstract

To investigate the relation between uricemia and lipid profile, 539 Arkhangelsk schoolgirls aged 7-17 were examined. With upper norm limit of 0. 31 mmol/l, the prevalence of asymptomatic chronic hyperuricemia among Arkhangelsk girls was as high as 25 %. With uricemia higher than 0. 31 mmol/l, total cholesterol, triglycerides, LDL cholesterol levels were significantly elevated. Mean total cholesterol levels in such individuals were higher than WHO norms of normocholesterolemia for children and adolescents. From the other hand, among individuals with dyslipidemia, uricemia more than 0. 31 mmol/l was diagnosed significantly more frequently. All measured lipid and liporotein parameters directly correlated with uricemia level, and inversely correlated with urate excretion rate, regardless of pathogenetic hyperuricemia mechanisms. Our results point to the fact that chronic hyperuricemia is assosiated with atherogenic lipid/lipoprotein phenotype, observed as early as in childhood, and possibly acts as an indicator of atherosclerosis risk. Therefore, use of a lower norm for population screening seems rational, from position of primary and secondary prevention of atherosclerosis. Our data support detailed examination of lipid metabolism if uricemia is higher than 0. 31 mmol/l.

About the Authors

S. I. Maljavskaya
Северный государственный медицинский университет
Russian Federation


T. A. Toropygina
Северный государственный медицинский университет
Russian Federation


V. E. Tril
Северный государственный медицинский университет
Russian Federation


V. A. Ternovskaya
Северный государственный медицинский университет
Russian Federation


References

1. Гланс С. Медико-биологическая статистика (пер. с англ.). М.: Прогресс, 1999. 460 с.

2. Agudelo C.A., Wise C.M. Gout: diagnosis, pathogenesis, and clinical manifestations. Curr. Opin. Rheumatol. 2001; 13 (3): 234-239.

3. Clausen J., Borch-Johnsen K., Ibsen H. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur. J. Endocrinol. 1998; 138 (1): 63-9.

4. Culleton B.F., Larson M.G., Kannel W.B., et al. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann. Intern. Med. 1999 Jul. 6; 131(1): 7-13.

5. Iwatani M., Wasada Т., Iwamoto Y., et al. Insulin sensitizer and urate metabolism. Nippon. Rinsho. 2000 Feb; 58(2): 430-495.

6. Johnson R.J., Tuttle K.R., Culleton B., et al. Much to do about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension. 2000; 35: 310-312.

7. Leyva F., Anker S., Swan J.W., et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur. Heart. J. 1997 May; 18(5): 858-65.

8. Leyva F., Wingrove C.S., Godsland I.F., et al. The glycolytic pathway to coronary heart disease: a hypothesis. Metabolism. 1998 Jun; 47(6): 657-62.

9. Nieto F.J., Iribarren C., Gross M.D., et al. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis, 2000. Jan; 148(1): 131-9.

10. Reaven G.M. The kidney: an unwilling accomplice in syndrome X. Am. J. Kidney Dis. 1997 Dec; 30(6): 928-31.

11. Staub M. Uric acid as a scavenger in oxidative stress. Orv. Hetil. 1999 Feb. 7; 140(6): 275-9.

12. Takahashi S., Yamamoto T., Tsutsumi Z., et al. Increased visceral fat accumulation in patients with primary gout. Adv. Exp. Med. Biol. 2000; 486: 131-4.


Review

For citations:


Maljavskaya S.I., Toropygina T.A., Tril V.E., Ternovskaya V.A. Lipoprotein profile in girls with asymptomatic hyperuricemia. Russian Journal of Cardiology. 2004;(1):33-37. (In Russ.)

Views: 328


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)